CRBP
Corbus Pharmaceuticals Holdings, Inc.
0.00 (0.00%)7.26USD553K成交股數140M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-16下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 1 · 25K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 308K · 3 |
| 其中 10b5-1 計畫賣出 | 3 筆 |
| 近 180 天 買進 · 賣出金額 | 126K · 381K |
| 近 180 天 淨額 | −255K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-15 | Ben Yong | Director | S 公開市場賣出(10b5-1) | 2.0K | 7.84 | 16K | 9.4K | SEC |
| 2026-08-16 | 08-17 | Nicacio Leonardo Viana | Chief Medical Officer | A 獲配股票 | 58.3K | – | – | 58.3K | SEC |
| 2026-08-11 | 08-12 | Saxena Nishant C | Chief Business Officer | P 公開市場買進 | 2.6K | 9.63 | 25K | 77.9K | SEC |
| 2026-08-07 | 08-10 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 17.0K | 10.08 | 171K | 157K | SEC |
| 2026-08-07 | 08-10 | Moran Sean F. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 12.0K | 10.08 | 121K | 84.7K | SEC |
| 2026-06-10 | 06-11 | Jenkins John Kenneth | Director | S 公開市場賣出(10b5-1) | 4.8K | 7.91 | 38K | 3.8K | SEC |
| 2026-06-10 | 06-11 | Altmeyer Anne | Director | S 公開市場賣出(10b5-1) | 2.4K | 7.91 | 19K | 7.6K | SEC |
| 2026-06-10 | 06-11 | Kung Winston | Director | S 公開市場賣出(10b5-1) | 2.0K | 7.91 | 16K | 12.1K | SEC |
| 2026-06-03 | 06-03 | Saxena Nishant C | Chief Business Officer | P 公開市場買進 | 9.0K | 7.58 | 68K | 75.3K | SEC |
| 2026-06-02 | 06-03 | Saxena Nishant C | Chief Business Officer | P 公開市場買進 | 4.5K | 7.33 | 33K | 66.3K | SEC |
| 2026-05-21 | 05-22 | Saxena Nishant C | Chief Business Officer | A 獲配股票 | 58.3K | – | – | 61.8K | SEC |
| 2026-05-19 | 05-21 | Altmeyer Anne | Director | A 獲配股票 | 3.8K | – | – | 10.0K | SEC |
| 2026-05-19 | 05-21 | Jenkins John Kenneth | Director | A 獲配股票 | 3.8K | – | – | 8.6K | SEC |
| 2026-05-19 | 05-21 | Ben Yong | Director | A 獲配股票 | 3.8K | – | – | 11.4K | SEC |
| 2026-05-19 | 05-21 | Jacques Rachelle Suzanne | Director | A 獲配股票 | 3.8K | – | – | 11.4K | SEC |
| 2026-05-19 | 05-21 | Pfeiffenberger Brent | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2026-05-19 | 05-21 | Kung Winston | Director | A 獲配股票 | 3.8K | – | – | 14.2K | SEC |
| 2026-03-02 | 03-04 | Smethurst Dominic | Chief Medical Officer | S 公開市場賣出 | 6.1K | 8.30 | 51K | 89.8K | SEC |
| 2026-02-17 | 02-18 | Hodgson Ian | Chief Operating Officer | S 公開市場賣出 | 847 | 7.38 | 6K | 51.1K | SEC |
| 2026-02-13 | 02-18 | Moran Sean F. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 7.78 | 37K | 96.7K | SEC |
| 2026-02-13 | 02-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 13.9K | 7.78 | 108K | 174K | SEC |
| 2026-02-03 | 02-04 | Hodgson Ian | Chief Operating Officer | S 公開市場賣出 | 2.4K | 8.09 | 20K | 51.9K | SEC |
| 2026-02-03 | 02-04 | Smethurst Dominic | Chief Medical Officer | S 公開市場賣出 | 3.3K | 8.09 | 27K | 95.9K | SEC |
| 2026-01-14 | 01-16 | Cohen Yuval | Chief Executive Officer | A 獲配股票 | 50.0K | – | – | 188K | SEC |
| 2026-01-14 | 01-16 | Moran Sean F. | Chief Financial Officer | A 獲配股票 | 28.1K | – | – | 101K | SEC |
| 2026-01-14 | 01-16 | Hodgson Ian | Chief Operating Officer | A 獲配股票 | 28.4K | – | – | 54.3K | SEC |
| 2026-01-14 | 01-16 | Smethurst Dominic | Chief Medical Officer | A 獲配股票 | 28.4K | – | – | 99.2K | SEC |
| 2025-12-11 | 12-15 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | S 公開市場賣出 | 30.0K | 11.46 | 344K | 2.3M | SEC |
| 2025-12-11 | 12-15 | Chen Bihua | TenPercentOwner | S 公開市場賣出 | 30.0K | 11.46 | 344K | 2.3M | SEC |
| 2025-12-11 | 12-15 | Cormorant Asset Management, LP | TenPercentOwner | S 公開市場賣出 | 30.0K | 11.46 | 344K | 2.3M | SEC |
| 2025-10-27 | 10-27 | Cohen Yuval | Chief Executive Officer | M 選擇權執行 | 9.0K | 4.26 | 38K | 147K | SEC |
| 2025-10-27 | 10-27 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 9.0K | 17.14 | 154K | 138K | SEC |
| 2025-10-24 | 10-27 | Cohen Yuval | Chief Executive Officer | M 選擇權執行 | 18.7K | 4.26 | 79K | 157K | SEC |
| 2025-10-24 | 10-27 | Moran Sean F. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.0K | 17.02 | 221K | 73.3K | SEC |
| 2025-10-24 | 10-27 | Moran Sean F. | Chief Financial Officer | M 選擇權執行 | 13.0K | 4.26 | 55K | 86.3K | SEC |
| 2025-10-24 | 10-27 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 18.7K | 17.01 | 317K | 138K | SEC |
| 2025-10-20 | 10-21 | Altmeyer Anne | Director | M 選擇權執行 | 1.1K | 4.80 | 5K | 7.3K | SEC |
| 2025-10-20 | 10-21 | Altmeyer Anne | Director | S 公開市場賣出(10b5-1) | 1.1K | 20.50 | 22K | 6.2K | SEC |
| 2025-05-30 | 06-02 | Jenkins John Kenneth | Director | A 獲配股票 | 4.8K | – | – | 4.8K | SEC |
| 2025-05-30 | 06-02 | Ben Yong | Director | A 獲配股票 | 4.8K | – | – | 7.6K | SEC |
| 2025-05-30 | 06-02 | Altmeyer Anne | Director | S 公開市場賣出(10b5-1) | 1.4K | 7.25 | 10K | 1.4K | SEC |
| 2025-05-30 | 06-02 | Jenkins John Kenneth | Director | S 公開市場賣出(10b5-1) | 2.8K | 7.35 | 20K | 33 | SEC |
| 2025-05-30 | 06-02 | Altmeyer Anne | Director | A 獲配股票 | 4.8K | – | – | 6.2K | SEC |
| 2025-05-30 | 06-02 | HOLMER ALAN F | Director | A 獲配股票 | 4.8K | – | – | 10.6K | SEC |
| 2025-05-30 | 06-02 | Jacques Rachelle Suzanne | Director | A 獲配股票 | 4.8K | – | – | 7.6K | SEC |
| 2025-05-30 | 06-02 | Kung Winston | Director | A 獲配股票 | 4.8K | – | – | 10.4K | SEC |
| 2025-03-06 | 03-07 | Smethurst Dominic | Chief Medical Officer | S 公開市場賣出 | 6.4K | 6.78 | 43K | 70.8K | SEC |
| 2025-02-14 | 02-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.1K | 8.76 | 62K | 138K | SEC |
| 2025-02-14 | 02-18 | Moran Sean F. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.8K | 8.76 | 24K | 73.3K | SEC |
| 2025-01-31 | 02-04 | Smethurst Dominic | Chief Medical Officer | A 獲配股票 | 27.2K | – | – | 77.2K | SEC |
| 2025-01-31 | 02-04 | Moran Sean F. | Chief Financial Officer | A 獲配股票 | 27.5K | – | – | 76.1K | SEC |
| 2025-01-31 | 02-04 | Cohen Yuval | Chief Executive Officer | A 獲配股票 | 68.1K | – | – | 145K | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 140K | 20.42 | 2.8M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 66.1K | 19.61 | 1.3M | 2.2M | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 25.9K | 18.36 | 476K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 45.1K | 17.48 | 788K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 25.8K | 22.23 | 573K | 2.4M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 47.6K | 21.47 | 1.0M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 140K | 20.42 | 2.8M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 66.1K | 19.61 | 1.3M | 2.2M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 25.9K | 18.36 | 476K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 47.6K | 21.47 | 1.0M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Chen Bihua | TenPercentOwner | P 公開市場買進 | 25.8K | 22.23 | 573K | 2.4M | SEC |
| 2024-09-20 | 09-24 | Cormorant Asset Management, LP | TenPercentOwner | P 公開市場買進 | 45.1K | 17.48 | 788K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 140K | 20.42 | 2.8M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 47.6K | 21.47 | 1.0M | 2.3M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 25.9K | 18.36 | 476K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 66.1K | 19.61 | 1.3M | 2.2M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 45.1K | 17.48 | 788K | 2.1M | SEC |
| 2024-09-20 | 09-24 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | P 公開市場買進 | 25.8K | 22.23 | 573K | 2.4M | SEC |
| 2024-08-16 | 08-20 | Kung Winston | Director | A 獲配股票 | 5.6K | – | – | 5.6K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | M 選擇權執行 | 11.7K | 30.00 | 350K | 96.1K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.8K | 42.24 | 75K | 84.4K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 11.7K | 42.24 | 493K | 84.4K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | M 選擇權執行 | 2.3K | 4.26 | 10K | 86.7K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.3K | 42.24 | 98K | 84.4K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.2K | 42.24 | 303K | 77.2K | SEC |
| 2024-06-18 | 06-18 | Cohen Yuval | Chief Executive Officer | M 選擇權執行 | 1.8K | 14.10 | 25K | 86.2K | SEC |
| 2024-06-18 | 06-18 | Moran Sean F. | Chief Financial Officer | M 選擇權執行 | 2.0K | 30.00 | 59K | 50.6K | SEC |
| 2024-06-18 | 06-18 | Moran Sean F. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.0K | 42.12 | 82K | 48.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 2.3M | 22.0M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 1.7M | 16.3M | 新進 | 新進 |
| BlackRock, Inc. | 1.3M | 12.5M | 新進 | 新進 |
| Aberdeen Group plc | 1.3M | 12.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 761K | 7.1M | 新進 | 新進 |
| Jones Hill Capital LP | 654K | 6.1M | 新進 | 新進 |
| Prosight Management, LP | 650K | 6.1M | 新進 | 新進 |
| Stonepine Capital Management, LLC | 425K | 4.0M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 423K | 4.0M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 422K | 4.0M | 新進 | 新進 |
| DIADEMA PARTNERS LP | 301K | 2.8M | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 293K | 2.8M | 新進 | 新進 |
| STATE STREET CORP | 255K | 2.4M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 190K | 1.8M | 新進 | 新進 |
| Exome Asset Management LLC | 185K | 1.7M | 新進 | 新進 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 152K | 1.4M | 新進 | 新進 |
| JANE STREET GROUP, LLC | 139K | 1.3M | 新進 | 新進 |
| NORTHERN TRUST CORP | 125K | 1.2M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 112K | 1.1M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 111K | 1.0M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 111K | 1.0M | 新進 | 新進 |
| DAFNA Capital Management LLC | 108K | 1.0M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 92.2K | 864K | 新進 | 新進 |
| Advisory Services Network, LLC | 90.0K | 844K | 新進 | 新進 |
| CANTOR FITZGERALD, L. P. | 80.2K | 752K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 107 +0 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 107 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 13.8M · 71.4% |
| 合計季末市值 | 129M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.2M |
|---|---|
| 與上期比 | +4.6% |
| 佔流通股數 | 11.61% |
| 日均成交量 | 612K |
| 回補天數 | 3.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.2M | +4.6% | 11.61% | 612K | 3.7 |
| 2026-08-14 | 2.1M | -6.6% | 11.10% | 355K | 6.0 |
| 2026-07-31 | 2.3M | +9.7% | 11.89% | 245K | 9.4 |
| 2026-07-15 | 2.1M | +7.8% | 10.84% | 355K | 5.9 |
| 2026-06-30 | 1.9M | +23.1% | 10.06% | 571K | 3.4 |
| 2026-06-15 | 1.6M | +3.3% | 8.17% | 465K | 3.4 |
| 2026-05-29 | 1.5M | +27.9% | 7.91% | 1.1M | 1.4 |
| 2026-05-15 | 1.2M | -15.1% | 6.18% | 307K | 3.9 |
| 2026-04-30 | 1.4M | +4.8% | 7.28% | 305K | 4.6 |
| 2026-04-15 | 1.3M | +10.9% | 6.95% | 219K | 6.1 |
| 2026-03-31 | 1.2M | -8.7% | 6.26% | 192K | 6.3 |
| 2026-03-13 | 1.3M | +0.8% | 6.86% | 255K | 5.2 |
| 2026-02-27 | 1.3M | +0.5% | 6.81% | 164K | 8.0 |
| 2026-02-13 | 1.3M | -2.2% | 6.77% | 145K | 9.0 |
| 2026-01-30 | 1.3M | +1.9% | 6.92% | 160K | 8.4 |
| 2026-01-15 | 1.3M | -0.0% | 6.80% | 185K | 7.1 |
| 2025-12-31 | 1.3M | +2.0% | 6.80% | 239K | 5.5 |
| 2025-12-15 | 1.3M | +26.6% | 6.66% | 632K | 2.0 |
| 2025-11-28 | 1.0M | +5.6% | 5.26% | 275K | 3.7 |
| 2025-11-14 | 964K | -8.2% | 4.98% | 517K | 1.9 |
| 2025-10-31 | 1.0M | +6.4% | 5.43% | 686K | 1.5 |
| 2025-10-15 | 986K | -15.8% | 5.10% | 262K | 3.8 |
| 2025-09-30 | 1.2M | -2.0% | 6.06% | 195K | 6.0 |
| 2025-09-15 | 1.2M | +3.0% | 6.18% | 74.6K | 16.0 |
| 2025-08-29 | 1.2M | -4.2% | 6.00% | 103K | 11.3 |
| 2025-08-15 | 1.2M | -2.4% | 6.27% | 97.3K | 12.5 |